An Evaluation Study of PET Image Quality Factors in Brain Tumor Diagnosis

<b>Objectives</b>: This retrospective, multi-center study analyzed pre-existing anonymized clinical data from electronic health records and imaging archives. The analysis utilized real-world clinical data from 200 patients across four tertiary care centers, without additional patient recruitment or interventions. This study aims to investigate the impact of metabolic and physiological factors-specifically blood glucose levels, cortisol concentrations, fasting duration, and tumor histology-on the quality and diagnostic reliability of <sup>18</sup>F-FDG PET/CT imaging in patients with primary brain tumors and inflammatory lesions. <b>Methods</b>: A total of 200 patients with primary brain tumors (including astrocytoma, glioblastoma, meningioma, and oligodendroglioma) were evaluated across four institutions using standardized protocols. The study examined the effects of prolonged fasting (>12 h), hyperglycemia (>150 mg/dL), and strict fasting (4-6 h) on tumor-to-background contrast and visual analog scale (DQS) scores. <b>Results</b>: Prolonged fasting was associated with elevated cortisol levels (correlation +0.54, <i>p</i> < 0.001), while hyperglycemia significantly reduced tumor SUVmax by up to 20% (r = -0.35, <i>p</i> = 0.012). Strict fasting and glucose control resulted in improved tumor-to-background contrast and DQS scores (r = +0.83, <i>p</i> < 0.001). Glioblastomas exhibited the highest SUVmax (9.1 ± 3.5), indicating aggressive metabolic activity, whereas meningiomas showed elevated cortisol levels (20.5 ± 6.8 µg/dL) linked to disruption of the hypothalamic-pituitary axis. Regression analysis confirmed that both cortisol and glucose levels independently degraded image quality (β = -0.25 and -0.18, respectively; <i>p</i> < 0.05). <b>Conclusions</b>: The findings highlight the necessity for harmonized patient preparation protocols. Recommendations are in alignment with the SNMMI Procedure Standard/EANM Practice Guideline for Brain [<sup>18</sup>F] FDG PET imaging.

Authors

Institutions

Publication Details

Journal
Tomography
Published
2026-02-05
DOI
https://doi.org/10.3390/tomography12020020
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
36.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Evaluation Study of PET Image Quality Factors in Brain Tumor Diagnosis

Ali Albweady
1 citations
Tomography
Glioma Diagnosis and Treatment
36.93
article

An Evaluation Study of PET Image Quality Factors in Brain Tumor Diagnosis

Ali Albweady
article en
1 citations

Abstract

<b>Objectives</b>: This retrospective, multi-center study analyzed pre-existing anonymized clinical data from electronic health records and imaging archives. The analysis utilized real-world clinical data from 200 patients across four tertiary care centers, without additional patient recruitment or interventions. This study aims to investigate the impact of metabolic and physiological factors-specifically blood glucose levels, cortisol concentrations, fasting duration, and tumor histology-on the quality and diagnostic reliability of <sup>18</sup>F-FDG PET/CT imaging in patients with primary brain tumors and inflammatory lesions. <b>Methods</b>: A total of 200 patients with primary brain tumors (including astrocytoma, glioblastoma, meningioma, and oligodendroglioma) were evaluated across four institutions using standardized protocols. The study examined the effects of prolonged fasting (>12 h), hyperglycemia (>150 mg/dL), and strict fasting (4-6 h) on tumor-to-background contrast and visual analog scale (DQS) scores. <b>Results</b>: Prolonged fasting was associated with elevated cortisol levels (correlation +0.54, <i>p</i> < 0.001), while hyperglycemia significantly reduced tumor SUVmax by up to 20% (r = -0.35, <i>p</i> = 0.012). Strict fasting and glucose control resulted in improved tumor-to-background contrast and DQS scores (r = +0.83, <i>p</i> < 0.001). Glioblastomas exhibited the highest SUVmax (9.1 ± 3.5), indicating aggressive metabolic activity, whereas meningiomas showed elevated cortisol levels (20.5 ± 6.8 µg/dL) linked to disruption of the hypothalamic-pituitary axis. Regression analysis confirmed that both cortisol and glucose levels independently degraded image quality (β = -0.25 and -0.18, respectively; <i>p</i> < 0.05). <b>Conclusions</b>: The findings highlight the necessity for harmonized patient preparation protocols. Recommendations are in alignment with the SNMMI Procedure Standard/EANM Practice Guideline for Brain [<sup>18</sup>F] FDG PET imaging.

TomographyVol. 12(2)
Qassim University (SA)
Qassim University
Openalex Percentile: Top 1%
Glioma Diagnosis and Treatment
36.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.